Skip to main content
This website uses cookies to ensure you get the best experience. By continuing to use this site, you agree to the use of cookies.

Please note: Your browser does not support the features used on Addgene's website. You may not be able to create an account or request plasmids through this website until you upgrade your browser. Learn more

Please note: Your browser does not fully support some of the features used on Addgene's website. If you run into any problems registering, depositing, or ordering please contact us at [email protected]. Learn more

Addgene
Bispecific antibodies targeting distinct regions of the spike protein potently neutralize SARS-CoV-2 variants of concern.
Cho H, Gonzales-Wartz KK, Huang D, Yuan M, Peterson M, Liang J, Beutler N, Torres JL, Cong Y, Postnikova E, Bangaru S, Talana CA, Shi W, Yang ES, Zhang Y, Leung K, Wang L, Peng L, Skinner J, Li S, Wu NC, Liu H, Dacon C, Moyer T, Cohen M, Zhao M, Lee FE, Weinberg RS, Douagi I, Gross R, Schmaljohn C, Pegu A, Mascola JR, Holbrook M, Nemazee D, Rogers TF, Ward AB, Wilson IA, Crompton PD, Tan J
Sci Transl Med. 2021 Oct 20;13(616):eabj5413. doi: 10.1126/scitranslmed.abj5413. Epub 2021 Oct 20.
PubMed Article

Plasmids from Article

ID Plasmid Purpose
172319pcDNA3.3-SARS2-B.1.617.1expressing SARS-CoV-2 B.1.617.1 (kappa strain) spike protein for pseudovirus production
172320pcDNA3.3-SARS2-B.1.617.2expressing SARS-CoV-2 B.1.617.2 spike protein (delta strain) for pseudovirus production.
177578pcDNA3.3_SARS2_Muexpressing SARS-CoV-2 B.1.621 (Mu) spike protein for pseudovirus production
177579pcDNA3.3_SARS2_Lambdaexpressing SARS-CoV-2 C.37 (lambda) spike protein for pseudovirus production

Antibodies from Article